Viewing Study NCT03666559


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-03-06 @ 1:17 PM
Study NCT ID: NCT03666559
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-29
First Post: 2018-06-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent IDH1/2 Mutated Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioma View
None IDH1/2 View
None Azacitidine View
None PFS View